Viome Life Sciences, maker of at-home tests for gut and immune system health, announced it has acquired digital health-and-wellness data company Naring Health, including its subsidiaries DiscernDX and Foodome.
Viome is split into two divisions, one selling consumer products like microbiome tests that provide diet recommendations and supplements, and the other focused on identifying biomarkers...
Allergy testing and treatment company Nectar Life Sciences announced the opening of the Nectar Allergy Center in New York, its first brick-and-mortar clinic, to expand its virtual care platform to a hybrid model.
Nectar, which launched earlier this year, offers at-home testing kits. Individuals can self-test for indoor or outdoor allergies and send their samples to Nectar for results.
Testers...
Vivoo, a startup that claims to offer personalized nutrition and lifestyle advice guided by urine tests, announced it has raised $6 million in Series A funding.
The round was led by Draper Associates, with participation from ONCE Ventures, Revo Capital, 500 Startups, Global Ventures and Halogen Ventures.
WHAT IT DOES
Vivoo offers at-home urine tests paired with a connected app that analyzes the...
Everlywell, a digital consumer platform for ordering and viewing lab tests from home, has closed an oversubscribed $175 million Series D funding round, the Austin, Texas-based company announced this morning.
The raise brought in a slew of new investors hailing from BlackRock, the Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures and Portfolia. It also saw...
Israel-based smartphone urinalysis and wound-care startup Healthy.io is purchasing fellow home-diagnostics company Inui Health in a roughly $9 million cash deal, CNBC reports.
The agreement also involves milestones that Inui Health will need to meet, and sees CEO Dr. Jaime Tenedorio take on a new role within Healthy.io's team.
MobiHealthNews has reached out to both companies for confirmation of...
Austin, Texas-based EverlyWell, a digital platform that lets consumers order lab tests online and view their results, has received an FDA Emergency Use Authorization (EUA) for a COVID-19 at-home diagnostic sample collection kit that can be used with multiple diagnostic lab tests.
Announced Friday by the FDA and Monday by the startup, the EverlyWell COVID-19 Test Home Collection Kit includes nasal...
Less than a week after the first home-collected saliva test for COVID-19 was authorized by the FDA, at least two consumer-facing telehealth brands say they have cut deals to sell these test kits to the public.
The first is consumer telehealth company Hims & Hers, best known for its mail-order wellness and sexual health products for men and women.
While the well-funded startup has...
Scanwell Health, maker of a smartphone-based platform for home urinary tract infection screening, has raised $3.5 million in seed funding. Founders Fund, Mayfield, DCM, Version One, Y Combinator and Liquid 2 Ventures all participated in the round.
The startup paired this announcement with the reveal of a new partnership with telehealth service Lemonaid Health that will bring its UTI platform to...
Israeli smartphone urinalysis startup Healthy.io has closed a $60 million Series C funding round led by Corner Ventures, the company announced this morning. Joy Capital Ventures and prior backers Ansonia Holdings, Aleph and Samsung NEXT each participated as well.
Furthermore, the company also announced that it has received a second FDA 510(k) clearance intended to support diagnosis of chronic...
Thriva, a London-based platform providing mail-order blood tests for consumers, has raised another $7.3 million in backing thanks to a new Series A round. Pembroke VCT and Guinness Asset Management were among the round’s participants, which brought the company’s total funds raised to $8.2 million.
WHAT THEY DO
Since 2016, Thriva has offered mail-order tests and results interpretations to more...
